Larvol Delta - Bellerophon-Therapeutics-Receives-IND-Clearance-from-China-NMPA-to-Conduct-Phase-3-Clinical-Trial-in-China-for-INOpulse-in-Fibrotic-Interstitial-Lung-Disease

INOpulse (nitric oxide) - Bellerophon Therap

https://www.globenewswire.com/news-release/2023/02/09/2605021/0/en/Bellerophon-Therapeutics-Receives-IND-Clearance-from-China-NMPA-to-Conduct-Phase-3-Clinical-Trial-in-China-for-INOpulse-in-Fibrotic-Interstitial-Lung-Disease.html

Feb 9, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next